Intradermal tacrolimus prevent scar hypertrophy in a rabbit ear model: A clinical, histological and spectroscopical analysis

Skin Research and Technology

Volumn 17, Issue 2, 2011, Pages 160-166

  Gisquet, Heloise ^a,b,c   Liu, Honghui ^a   Blondel, W C P M ^a   Leroux, Agnes ^b   Latarche, Clothilde ^c   Merlin, J L ^b   Chassagne, J F ^c   Peiffert, Didier ^b   Guillemin, François ^b  

^a CENTRE DE RECHERCHE EN AUTOMATIQUE DE NANCY   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Hypertrophic scar; Keloid; Rabbit ear model; Skin spectroscopy; Tacrolimus

Indexed keywords

CELLULAR DENSITY; CLINICAL EXAMINATION; HYPERTROPHIC SCAR; IN-VIVO; INTRADERMAL INJECTION; KELOID; NON-INVASIVE; NORMAL SKIN; OPTICAL SPECTROSCOPY; RABBIT EAR MODEL; RELAPSE RATES; SIDE EFFECT; TACROLIMUS; THERAPEUTIC METHOD; TISSUE CHARACTERIZATION;

RATING;

TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; DRUG EFFICACY; DRUG TOLERABILITY; EXPERIMENTAL RABBIT; FEMALE; HISTOPATHOLOGY; HYPERTROPHIC SCAR; NAIL DYSCHROMIA; NONHUMAN; OPTIMAL DRUG DOSE; SKIN ATROPHY; SKIN INFECTION; SKIN INFLAMMATION; SKIN NECROSIS; SKINFOLD THICKNESS; SPECTROSCOPY; TELANGIECTASIA; TREATMENT RESPONSE;

ANIMALS; CICATRIX, HYPERTROPHIC; DERMOSCOPY; DISEASE MODELS, ANIMAL; EAR, EXTERNAL; FEMALE; HYPERTROPHY; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRADERMAL; KELOID; RABBITS; SPECTRUM ANALYSIS; TACROLIMUS; WOUNDS AND INJURIES;

EID: 79953081328     PISSN: 0909752X     EISSN: 16000846     Source Type: Journal    
DOI: 10.1111/j.1600-0846.2010.00479.x     Document Type: Article

References (34)

1. Burd A. Keloid epidemiology: population based studies needed. J Plast Reconstr Aesthet Surg 2006; 59: 105.
2. Robles DT, Moore E, Draznin M, Berg D. Keloids: pathophysiology and management. Dermatol Online J 2007; 13: 9.
3. Darzi MA, Chowdri NA, Kaul SK, Khan M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg 1992; 45: 374-379.
4. Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997; 37: 755-757.
5. Peiffert D, Chassagne JF, Pernot M, Hoffstetter S, Dinh-Doan G, Benyacoub N, Abs R, Stricker M. Surgery and curietherapy of keloids. Rev Stomatol Chir Maxillofac 1995; 96: 108-112.
6. Mustoe TA, Cooter RD, Gold MH, Hobbs FD, Ramelet AA, Shakespeare PG, Stella M, Téot L, Wood FM, Ziegler UE. International clinical recommendations on scar management. Plast Reconstr Surg 2002; 110: 560-571.
7. Berman B, Villa A. Imiquimod 5% cream for keloid management. Dermatol Surg 2003; 29: 1050-1051.
8. * brachytherapy: a retrospective study. J Eur Acad Dermatol Venereol 2009; 23: 807-813.
9. Butt M, Connolly D, Lip GY. Drug-eluting stents: a comprehensive appraisal. Future Cardiol 2009; 5: 141-157.
10. Hiroi J. Pharmacological profile and clinical effect of tacrolimus ointment (protopic ointment) for atopic dermatitis. Nippon Yakurigaku Zasshi 2001; 117: 351-357.
11. Hultsch T, Kapp A, Spergel J. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005; 211: 174-187.
12. Khorshid FA. Comparative study of keloid formation in humans and laboratory animals. Med Sci Monit 2005; 11: BR212-BR219.
13. Ramos ML, Gragnani A, Ferreira LM. Is there an ideal animal model to study hypertrophic scarring? J Burn Care Res 2008; 29: 363-368.
14. Zhu GY, Xu B, Cai JL. Experimental research of correlation between anatomy structure of rabbit ear and creating hypertrophic scar animal model. Zhonghua Zheng Xing Wai Ke Za Zhi 2008; 24: 216-219.
15. Kloeters O, Tandara A, Mustoe TA. Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen 2007; 15 (Suppl 1): S40-S45.
16. Bigio IJ, Mourant JR. Ultraviolet and visible spectroscopies for tissue diagnostics: fluorescence spectroscopy and elastic-scattering spectroscopy. Phys Med Biol 1997; 42: 803-814.
17. Tuchin V. Handbook of optical biomedical diagnostics. Bellingham, USA: SPIE, 2002: 675-724.
18. Chang SK, Mirabal YN, Atkinson EN, Cox D, Malpica A, Follen M, Richards-Kortum R. Combined reflectance and fluorescence spectroscopy for in vivo detection of cervical pre-cancer. J Biomed Opt 2005; 10: 024031.
19. Georgakoudi I, Jacobson BC, Van Dam J et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology 2001; 120: 1620-1629.
20. Diaz-Ayil G, Amouroux M, Blondel WCPM, Bourg-Heckly G, Leroux A, Guillemin F, Granjon Y. Bimodal spectroscopic evaluation of ultra violet-irradiated mouse skin inflammatory and precancerous stages: instrumentation, spectral feature extraction/selection and classification (k-NN, LDA and SVM). Eur Phys J - Appl Phys 2009; 47: 12707.
21. Amouroux M, Diaz-Ayil G, Blondel WCPM, Bourg-Heckly G, Leroux A, Guillemin F. Classification of ultraviolet irradiated mouse skin histological stages by bimodal spectroscopy: multiple excitation autofluorescence and diffuse reflectance. J Biomed Opt 2009; 14: 014011.
22. Pery E, Blondel WCPM, Didelon J, Leroux A, Guillemin F. Simultaneous characterization of optical and rheological properties of carotid arteries via bimodal spectroscopy: experimental and simulation results. IEEE Trans Biomed Eng 2009; 56: 1267-1276.
23. Ju-Lin X, Shao-Hai Q, Tian-Zeng L, Bin H, Jing-Ming T, Ying-Bin X, Xu-Sheng L, Bin S, Hui-Zhen L, Yong H. Effect of asiaticoside on hypertrophic scar in the rabbit ear model. J Cutan Pathol 2009; 36: 234-239.
24. Brown RJ, Lee MJ, Sisco M, Kim JY, Roy N, Mustoe TA. High-dose ultraviolet light exposure reduces scar hypertrophy in a rabbit ear model. Plast Reconstr Surg 2008; 121: 1165-1172.
25. Berman B, Villa AM, Ramirez CC. Novel opportunities in the treatment and prevention of scarring. J Cutan Med Surg 2004; 8 (Suppl 3): 32-36.
26. Berman B, Viera MH, Amini S, Huo R, Jones IS. Prevention and management of hypertrophic scars and keloids after burns in children. J Craniofac Surg 2008; 19: 989-1006.
27. Dean PG, Lund WJ, Larson TS, Prieto M, Nyberg SL, Ishitani MB, Kremers WK, Stegall MD. Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus. Transplantation 2004; 77: 1555-1561.
28. Sabate M. Secondary revascularisation following intracoronary brachytherapy. EuroIntervention 2009; 5 (Suppl D): D121-D126.
29. Kryger ZB, Sisco M, Roy NK, Lu L, Rosenberg D, Mustoe TA. Temporal expression of the transforming growth factor-Beta pathway in the rabbit ear model of wound healing and scarring. J Am Coll Surg 2007; 205: 78-88.
30. Liu W, Wang DR, Cao YL. TGF-beta: a fibrotic factor in wound scarring and a potential target for anti-scarring gene therapy. Curr Gene Ther 2004; 4: 123-136.
31. Lu L, Saulis AS, Liu WR, Roy NK, Chao JD, Ledbetter S, Mustoe TA. The temporal effects of anti-TGF-beta 1, 2, and 3 monoclonal antibody on wound healing and hypertrophic scar formation. J Am Coll Surg 2005; 201: 391-397.
32. Bekersky I, Lilja H, Lawrence I. Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic. Semin Cutan Med Surg 2001; 20: 226-232.
33. Hasegawa T, Sumiyoshi K, Tsuchihashi H, Ikeda S, Nakao A, Ogawa H. FK506 inhibits the enhancing effects of TGF-beta on wound healing in a rabbit dermal ulcer model. J Dermatol Sci 2007; 47: 37-40.
34. Chen G, Chen J, Zhuo S, Xiong S, Zeng H, Jiang X, Chen R, Xie S. Nonlinear spectral imaging of human hypertrophic scar based on two-photon excited fluorescence and second-harmonic generation. Br J Dermatol 2009; 161: 48-55.